Dlh / vlastný kapitál spoločnosti Agios Pharmaceuticals Inc
Aká je hodnota metriky Dlh / vlastný kapitál spoločnosti Agios Pharmaceuticals Inc?
Hodnota metriky Dlh / vlastný kapitál spoločnosti Agios Pharmaceuticals Inc je 0.16
Aká je definícia metriky Dlh / vlastný kapitál?
Dlh / vlastný kapitál (Debt to equity ratio) ukazovateľ vyjadruje pomer vlastného kapitálu a cudzích zdrojov na financovanie majetku spoločnosti.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dlh / vlastný kapitál spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Agios Pharmaceuticals Inc
Čomu sa venuje spoločnosť Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Firmy s metrikou dlh / vlastný kapitál podobnou spoločnosti Agios Pharmaceuticals Inc
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Crowd Media je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Katoro Gold plc je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Hengxing Gold je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti The Westaim je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Latin Metals je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Primeton Information Technologies je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Agios Pharmaceuticals Inc je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Colossus Resources Corp je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti MaxCyte je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Nihon M&A Center je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Protara Therapeutics Inc je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti OCI International je 0.16
- Hodnota metriky Dlh / vlastný kapitál spoločnosti CS Disco je 0.16